SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-190044
Filing Date
2024-07-31
Accepted
2024-07-31 17:25:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d852087d424b3.htm 424B3 88933
2 GRAPHIC g852087g11a01.jpg GRAPHIC 36739
  Complete submission text file 0001193125-24-190044.txt   140837
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280919 | Film No.: 241163103
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)